Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation
NCT04232722 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 43
Last updated 2020-01-18
Summary
To analyze the safety, efficacy and pharmacokinetic characteristics of sorafenib combined with compound huangdai tablets in patients with recurrent hepatocellular carcinoma after liver transplantation
Conditions
Interventions
- DRUG
-
Arsenicals
As4 S4
Sponsors & Collaborators
-
Zhejiang University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-01
- Primary Completion
- 2021-12-31
- Completion
- 2022-06-30
Countries
- China
Study Locations
More Related Trials
-
Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients
NCT00997022 ·Status: COMPLETED ·Phase: PHASE1
-
Carelizumab Combined With Regorafenib in the Treatment of HCC（CARE-2020）
NCT04806243 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma
NCT01328223 ·Status: UNKNOWN
-
Combined Treatment of RFA and Sorafenib on Recurrent HCC
NCT01470495 ·Status: UNKNOWN ·Phase: NA
-
The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection
NCT03253250 ·Status: UNKNOWN ·Phase: PHASE4
-
A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma
NCT01308723 ·Status: COMPLETED ·Phase: PHASE1
-
Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors
NCT07337421 ·Status: RECRUITING ·Phase: PHASE2
-
Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib
NCT00812175 ·Status: COMPLETED
-
Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
NCT01348503 ·Status: TERMINATED ·Phase: PHASE1
-
The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma
NCT01972672 ·Status: COMPLETED ·Phase: PHASE2
-
A Single Center Real-world Study of Donafenib in the Treatment of Hepatocellular Carcinoma in Routine Clinical Practice
NCT05200221 ·Status: UNKNOWN
-
Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma
NCT04642547 ·Status: COMPLETED ·Phase: NA
-
A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma
NCT00044512 ·Status: COMPLETED ·Phase: PHASE2
-
Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcinoma
NCT05048017 ·Status: RECRUITING ·Phase: PHASE2
-
Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma
NCT04168944 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma
NCT00943449 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of Lenvatinib Combined With Chinese Herbal Medicine for Patients With Unresectable Hepatocellular Carcinoma: A Real-world Study in China
NCT06315101 ·Status: COMPLETED
-
Effect of Biejia-Ruangan Compound on Survival Rate and Recurrence Rate of Hepatocellular Carcinoma After Radical Treatment
NCT06923176 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE
NCT03722498 ·Status: WITHDRAWN ·Phase: PHASE2
-
Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety
NCT01908322 ·Status: COMPLETED
-
Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma
NCT02834546 ·Status: COMPLETED
-
A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma
NCT04194775 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
NCT05444478 ·Status: RECRUITING ·Phase: NA
-
Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant
NCT00844168 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC
NCT03516071 ·Status: COMPLETED ·Phase: PHASE2